chlordiazepoxide hydrochloride and clidinium bromide
- Product NDC
- 23155-808
- 11-digit product format
- 231550808
- Labeler code
- 23155
- Product ID
- 23155-808_d8a7aa0f-4337-7366-e053-2995a90acce3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- chlordiazepoxide hydrochloride and clidinium bromide
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- Application
- ANDA210579
- Marketing category
- ANDA
- Marketing start
- 2022-01-01
- Marketing end
- 0000-00-00
- Substance
- CHLORDIAZEPOXIDE; CLIDINIUM BROMIDE
- Active strength
- 5 mg/1; mg/1
- Pharmacologic classes
- Anticholinergic [EPC], Benzodiazepine [EPC], Benzodiazepines [CS], Cholinergic Antagonists [MoA], Decreased Parasympathetic Acetylcholine Activity [PE], Digestive/GI System Activity Alteration [PE], GI Motility Alteration [PE]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 23155-808-01 | 23155080801 | 100 CAPSULE in 1 BOTTLE, PLASTIC (23155-808-01) | 100 capsule | 2022-01-01 | 0000-00-00 | No | No | Current |